According to recent reports, notably in the British Medical Journal, viral resistance is making existing AIDS drugs less effective and others totally useless. Meanwhile, the development of new AIDS drugs is in shocking decline, down by 33 percent over the past five years. The Bush administration seems to be unaware, and big pharma is unwilling to admit, that this decreased development is a nasty consequence of drug activists succeeding in their campaign to demand lower prices for AIDS drugs.
